| Document Date: 2015-03-16 01:05:14
Open Document File Size: 203,72 KBShare Result on Facebook
Company AEs / N/A Software / A.Menarini Australia Pty Ltd / BSC INC / New England Journal / PSCR / / Continent Europe / / Country United States / Australia / / Currency USD / / Event Product Issues / Product Recall / FDA Phase / / Facility Consumer Comments facility / Private Hospital / Public Hospital / / Holiday Commonwealth Day / / IndustryTerm treatment / withdrawal / Treatment of Muckle-Wells syndrome / treatment of familial cold autoinflammatory syndrome / / MarketIndex EGX 30 / / MedicalCondition prescribed chronic therapy / Rheumatism / stable familial cold autoinflammatory syndrome / headache / severe cryopyrin-associated periodic syndromes / Arthritis / Muckle‐Wells Syndrome / rheumatoid arthritis / normal urticaria / severe active rheumatoid arthritis / sensorineural hearing loss / disease activity score / neonatal onset multisystem inflammatory disease / psoriasis / Hearing loss / Familial Cold Autoinflammatory Syndrome / infections / cryopyrin-associated periodic syndromes / Papilledema / pneumonia / Muckle-Wells syndrome / mental retardation / disease / gastroenteritis / Bone dysplasia / Rheumatic Diseases / chronic / rare disease / cutaneous / articular syndrome / CINCA syndrome / fever / NOMID/CINCA syndrome / rare autoinflammatory diseases / vomiting / pain / Articular Syndrome / diseases / active moderate-to-severe disease / neonatal-onset multisystem inflammatory disease / urticaria-like skin rash / renal failure / rash / joint pain / autoinflammatory Muckle-Wells syndrome / rash / joint pain / inflammatory / periodic syndrome / / MedicalTreatment renal transplants / / MusicGroup Excel / / Organization Autoinflammatory Alliance / Public Hospital / Australian Committee on Prescription Medicines / Private Hospital / / Person Time / Outcomes Response / / Position TGA Clinical Evaluator / model / Dental Medical Practitioners Nurse / nurse / Private / / Product group / Kineret / patients / study / period / AR-0298 / / PublishedMedium PloS ONE / The New England Journal of Medicine / / Region New England / / Technology submission Study ID Protocol / simulation / /
SocialTag |
5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of Application